Spectroscopic optical cohernece tomography for intravascular imaging

Information

  • Research Project
  • 7482059
  • ApplicationId
    7482059
  • Core Project Number
    R43HL092690
  • Full Project Number
    1R43HL092690-01
  • Serial Number
    92690
  • FOA Number
    PA-07-80
  • Sub Project Id
  • Project Start Date
    6/1/2008 - 16 years ago
  • Project End Date
    5/31/2009 - 15 years ago
  • Program Officer Name
    BUXTON, DENIS B.
  • Budget Start Date
    6/1/2008 - 16 years ago
  • Budget End Date
    5/31/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/23/2008 - 16 years ago

Spectroscopic optical cohernece tomography for intravascular imaging

[unreadable] DESCRIPTION (provided by applicant): The overall objective of this SBIR project is the development of a rapid, high resolution optical method for in vivo imaging with a specific emphasis on intravascular imaging and the identification of vulnerable plaque. The approach uses a novel harmonic detection method for optical coherence tomography (OCT) that will allow depth resolved near infrared spectroscopy in conjunction with structural imaging. Since different structures in atherosclerotic plaques, such as the fibrotic caps, lipid pools and calcifications have different near infrared spectroscopic features, spectroscopic OCT is a promising approach to enhancing contrast in optical coherence tomography. [unreadable] Southwest Sciences recently developed a harmonic detection method for optical coherence tomography for the removal of artifacts inherent to Fourier domain OCT, but the method can also be used to provide the phase information necessary for spectroscopic OCT. Harmonic detection is easily applied because it uses a simple sine- wave modulation of the interferometer, with detection at harmonics of the applied wave. [unreadable] Phase I of this project focuses on demonstrating spectroscopic OCT using our harmonic detection technology. In particular, a near infrared absorption feature of lipid, which is an important component of vulnerable atherosclerotic plaques, will be used to demonstrate contrast enhancement resulting from spectroscopic OCT. In Phase II, we will proceed with design and construction of a fiber-optic, catheter probe instrument for intra-luminal imaging of arteries, with the goal of conducting Phase III clinical studies. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    112931
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:112931\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SOUTHWEST SCIENCES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SANTA FE
  • Organization State
    NM
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    87505
  • Organization District
    UNITED STATES